Sipavibart

Kavigale

150 MG / ML SolutionCanadaAuthorised

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Kavigale 300 MG Solucion Inyectable y Para PerfusionSpain · 300 mg · solución inyectable y para perfusión · Astrazeneca AbSame brand
KavigaleEuropean Union · AstraZeneca ABSame brand
KavigaleCroatiaSame brand
KavigaleItaly · Soluzione iniettabile o per infusione · Astrazeneca ABSame brand
KAVIGALE 300 mg oplossing voor injectie/infusieNetherlands · Oplossing voor injectie of infusie · AstraZeneca ABSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sipavibart

Kavigale

150 MG / ML SolutionCanadaAuthorised

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Sipavibart
Strength: 150 MG / ML
Dosage form: Solution
Route: Intramuscular, Intravenous
Register: Canada (Health Canada)
Status: Authorised
Status in the register: Approved
Registration: DIN 02556332
Marketing authorisation holder: Astrazeneca Canada INC
ATC code: J06BD09
Group: Anti-infectives for systemic use
Supply: PRESCRIPTION, SCHEDULE D